Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Visible Genetics Inc.(VGIN) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Haugland who wrote (242)	10/20/1998 2:23:00 PM
From: Steve Lokness	Respond to of 337

Thanks Richard for the update. The question I asked two post ago takes on a whole new look with the news of this patent. I asked if the DIGE test for viral load might in fact be complimentary to VGINF's test, but instead with this patent it looks like DIGE will get some competition from VGINF! If VGINF can test for viral load AND genotype at the same time what an advantage. Wonder who VGINF might connect up with to produce this test? Wonder why they don't want to go it alone? Kivtan